US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

Direxion Daily Biotech Top 5 Bull 2X ETF

44.42

+1.092.52%

Volume:6K

Turnover:275.32K

Market Cap:5.55M

PE:- -

High:45.10

Open:43.74

Low:43.74

Close:43.33

52wk High:45.10

52wk Low:25.71

Shares:125.00K

Float Shares:125.00K

Volume Ratio:0.49

T/O Rate:4.91%

Dividend:0.62

Dividend Rate:1.40%

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Argenx Se : TD Cowen Raises Target Price to $1353 from $1146

THOMSON REUTERS

Argenx Se : Truist Securities Raises Target Price to $1095 from $1030

THOMSON REUTERS

Amgen Inc. Stock Outperforms Competitors on Strong Trading Day

ADRs Close Higher; Argenx SE Climbs 16%

William Blair says Argenx’s ALKIVIA results boost confidence in Vyvgart DM path

Argenx Stock Heads for Record After Blockbuster Drug Delivers Another Win

Vortex Energy Appoints Market Maker to Boost Liquidity on CSE

argenx SE Stock (ARGX) Moved Up by 16.67% on Aug 17: Drivers Behind the Movement

Argenx Price Target Raised to $1215.00/Share from $1075.00 by Piper Sandler

European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading

MT Newswires Live

Wedbush Adjusts Argenx PT to $1,150 From $1,050, Maintains Outperform Rating

MT Newswires Live

Argenx SE (ARGX) Stock Soars 15% on Positive Phase 3 Study Results

Argenx SE up over 15%, on Pace for Largest Percent Increase Since July 2023

Argenx rises 14.9%

Sector Update: Healthcare

MT Newswires Live

Regeneron Pharma Price Target Raised to $824.00/Share from $641.00 by Leerink Partners

EyePoint Tumbles After Experimental Eye Drug Misses Main Goal in Late-Stage Study

Argenx price target raised to $1,215 from $1,075 at Piper Sandler

argenx Says Autoimmune Myositis Drug Meets Main Goal in Phase 3 Study

MT Newswires Live

Argenx Shares Rise After Positive Results from Phase 3 Study of Efgartigimod

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers HK | Online Trading in stocks, bonds & ETFS","description":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","keywords":"tiger trading,tiger security,tiger broker hk,tigers co ltd,tiger trade hk,tiger brokers hk,stock broker,securities broker,online brokerage,hong kong broker,hk broker,online stock trading,online trading platform,stock trading platforms,trading application,stock trading,stock trading hong kong,buying stocks in hong kong,tiger brokers","social":{"ogDescription":"Discover Tiger Brokers HK, an online trading platform for stocks&ETFs, options&futures, bonds and crypto. Open an account to enjoy low commission trading today!","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.gotigerhk.com/stock/TBXU/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"HKG","license":"TBHK","edition":"fundamental","symbol":"TBXU","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","market":"US","secType":"STK","nameCN":"Direxion Daily Biotech Top 5 Bull 2X ETF","latestPrice":44.4163,"timestamp":1787342400000,"preClose":43.3255,"halted":0,"volume":6138,"delay":0,"changeRate":0.025176858893723134,"floatShares":125000,"shares":125000,"eps":0,"marketStatus":"Pre-Mkt","change":1.0908,"latestTime":"08-24 06:38:04 EDT","open":43.74,"high":45.1,"low":43.74,"amount":275315,"amplitude":0.03139,"askPrice":70.62,"askSize":100,"bidPrice":17.87,"bidSize":100,"shortable":3,"etf":2,"ttmEps":0,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1787578200000},"marketStatusCode":1,"adr":0,"exchange":"ARCA","adjPreClose":44.4163,"sharesOutstanding":100001,"nav":44.376,"aum":5547067.57,"dividendRate":0.013999,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":44.37,"preClose":44.4163,"latestTime":"16:10 EDT","volume":6,"amount":266.4978,"timestamp":1787343004463,"change":-0.0463,"changeRate":-0.001042,"amplitude":0},"volumeRatio":0.48867870216547865},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TBXU\",,,,,undefined,":{"symbol":"TBXU","floatShares":125000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.48867870216547865,"shares":125000,"dividePrice":0.6218,"high":45.1,"amplitude":0.03139,"preClose":43.3255,"low":43.74,"week52Low":25.71,"pbRate":"--","week52High":45.1,"institutionHeld":0,"latestPrice":44.4163,"eps":0,"divideRate":0.013999,"volume":6138,"delay":0,"ttmEps":0,"open":43.74,"prevYearClose":31.065,"prevWeekClose":44.4163,"prevMonthClose":34.3127,"prevQuarterClose":32.1223,"fiveDayClose":37.6716,"twentyDayClose":32.6163,"sixtyDayClose":28.9991},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TBXU\",params:#limit:5,,,undefined,":[{"date":"2026-06-23","symbol":"TBXU","amount":0.11101,"announcedDate":"2026-06-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-06-23","defaultRemindTime":1782221400000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-06-30","payableDate":"2026-06-23","currency":"USD","dateTimestamp":1782187200000,"payDate":"2026-06-30"},{"date":"2026-03-24","symbol":"TBXU","amount":0.09893,"announcedDate":"2026-03-23","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2026-03-24","defaultRemindTime":1774359000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2026-03-31","payableDate":"2026-03-24","currency":"USD","dateTimestamp":1774324800000,"payDate":"2026-03-31"},{"date":"2025-12-23","symbol":"TBXU","amount":0.10111,"announcedDate":"2025-12-22","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-23","defaultRemindTime":1766500200000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-31","payableDate":"2025-12-23","currency":"USD","dateTimestamp":1766466000000,"payDate":"2025-12-31"},{"date":"2025-12-10","symbol":"TBXU","amount":0.31143,"announcedDate":"2025-12-09","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-10","defaultRemindTime":1765377000000,"name":"Direxion Daily Biotech Top 5 Bull 2X ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-17","payableDate":"2025-12-10","currency":"USD","dateTimestamp":1765342800000,"payDate":"2025-12-17"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TBXU\",market:\"US\",,,undefined,":[{"executeDate":"2025-12-10","recordDate":"2025-12-10","paymentDate":"2025-12-17","value":0.31143,"currency":"USD"},{"executeDate":"2025-12-23","recordDate":"2025-12-23","paymentDate":"2025-12-31","value":0.10111,"currency":"USD"},{"executeDate":"2026-03-24","recordDate":"2026-03-24","paymentDate":"2026-03-31","value":0.09893,"currency":"USD"},{"executeDate":"2026-06-23","recordDate":"2026-06-23","paymentDate":"2026-06-30","value":0.11101,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TBXU\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TBXU\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2660451398","title":"Argenx Se : TD Cowen Raises Target Price to $1353 from $1146","url":"https://stock-news.laohu8.com/highlight/detail?id=2660451398","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660451398?lang=en_us&edition=fundamental","pubTime":"2026-08-18 12:16","pubTimestamp":1787026573,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nFWN44E0RL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00BJJMRZ35.SGD","LU0823416689.USD","IE00BJT1NW94.SGD","IE00B2B36J28.USD","ARGX","IE0009355771.USD","IE0034235188.USD","BK4505","LU0320765992.SGD","LU0109394709.USD","IE00B4R5TH58.HKD","LU1983260115.SGD","LU0889565916.HKD","FMED","LU2324357040.USD","TBXU","IE00BFTCPJ56.SGD","BK4585","BK4588","IBB","BK4139","IE0002141913.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660456165","title":"Argenx Se : Truist Securities Raises Target Price to $1095 from $1030","url":"https://stock-news.laohu8.com/highlight/detail?id=2660456165","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660456165?lang=en_us&edition=fundamental","pubTime":"2026-08-18 10:39","pubTimestamp":1787020796,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260818:nFWN44E0QM:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4588","BK4139","IE00B2B36J28.USD","IE0002141913.USD","IE00BJJMRZ35.SGD","LU0823416689.USD","LU2324357040.USD","IE0009355771.USD","LU0109394709.USD","IE00BJT1NW94.SGD","LU0889565916.HKD","BK4505","ARGX","LU0320765992.SGD","BK4585","LU1983260115.SGD","FMED","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","TBXU","IBB","IE0034235188.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660543294","title":"Amgen Inc. Stock Outperforms Competitors on Strong Trading Day","url":"https://stock-news.laohu8.com/highlight/detail?id=2660543294","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660543294?lang=en_us&edition=fundamental","pubTime":"2026-08-18 04:34","pubTimestamp":1786998840,"startTime":"0","endTime":"0","summary":"DJ Amgen Inc. Stock Outperforms Competitors On Strong Trading DayThis article was automatically generated by MarketWatch using technology from Automated Insights.Shares of Amgen Inc.  rose 1.00% to $419.38 Monday, on what proved to be an all-around poor trading session for the stock market, with the S&P 500 Index  falling 0.52% to 7,745.06 and Dow Jones Industrial Average  falling 0.51% to 53,459.78.Amgen Inc. closed 0.57% below its 52-week high of $421.79, which the company achieved on August 11th.The stock outperformed some of its competitors Monday, as Johnson & Johnson  rose 0.78% to $262.37, Pfizer Inc.  rose 0.30% to $26.87, and AbbVie Inc.  rose 0.35% to $250.33.Trading volume  remained 239,213 below its 50-day average volume of 2.8 M.Data source: Dow Jones Market Data, FactSet. Data compiled August 17, 2026.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["04332","IE0009355771.USD","LU2468319806.SGD","LU1061106388.HKD","LU0122379950.USD","LU2242646821.SGD","LU0058720904.USD","AMGN","LU0889565916.HKD","BIB","LU2242652126.USD","BK4588","PJP","LU1023059063.AUD","LU2112291526.USD","LU0868494617.USD","LU0289739699.SGD","BK4599","IE00BFTCPJ56.SGD","LU0109394709.USD","LU1057294990.SGD","IE00BJT1NW94.SGD","IBB","LU0320765992.SGD","PBE","BBH","IBBQ","IE00B2B36J28.USD","LU1983299246.USD","LU2089984988.USD","TBXU","BK4533","SG9999001440.SGD","BK4566","BK4139","IE0002141913.USD","BK4581","BK4534","BK4585","LU1571399168.USD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660432656","title":"ADRs Close Higher; Argenx SE Climbs 16%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660432656","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660432656?lang=en_us&edition=fundamental","pubTime":"2026-08-18 04:31","pubTimestamp":1786998660,"startTime":"0","endTime":"0","summary":"This article was automatically generated by Dow Jones using technology from Automated Insights.International stocks trading in New York closed higher on Monday, as the S&P/BNY Mellon index of American","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","IE0009355771.USD","BK4505","IE0034235188.USD","IBB","LU0109394709.USD","BK4139","ARGX","LU0823416689.USD","LU1983260115.SGD","IE00BFTCPJ56.SGD","LU2324357040.USD","LU0889565916.HKD","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","FMED","SCHY","BK4585","IE0002141913.USD","IE00BJT1NW94.SGD","BK4588","TBXU","IE00B2B36J28.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660888434","title":"William Blair says Argenx’s ALKIVIA results boost confidence in Vyvgart DM path","url":"https://stock-news.laohu8.com/highlight/detail?id=2660888434","media":"TIPRANKS","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660888434?lang=en_us&edition=fundamental","pubTime":"2026-08-18 02:20","pubTimestamp":1786990827,"startTime":"0","endTime":"0","summary":"William Blair notes that Argenx (ARGX) announced top-line results from the Phase III ALKIVIA trial of Vyvgart in autoimmune myositis, showing a cli...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/william-blair-says-argenxs-alkivia-results-boost-confidence-in-vyvgart-dm-path-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/william-blair-says-argenxs-alkivia-results-boost-confidence-in-vyvgart-dm-path-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["IE0034235188.USD","LU1983260115.SGD","LU0109394709.USD","TBXU","FMED","IE0009355771.USD","BK4139","ARGX","IE00BJT1NW94.SGD","LU0823416689.USD","BK4505","LU2324357040.USD","LU0889565916.HKD","IE0002141913.USD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","IBB","LU0320765992.SGD","BK4585","BK4588"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660431479","title":"Argenx Stock Heads for Record After Blockbuster Drug Delivers Another Win","url":"https://stock-news.laohu8.com/highlight/detail?id=2660431479","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660431479?lang=en_us&edition=fundamental","pubTime":"2026-08-18 02:04","pubTimestamp":1786989840,"startTime":"0","endTime":"0","summary":"Argenx's autoimmune drug Vyvgart achieved blockbuster status in just its second full year on the market. Now, the Dutch biotech is looking to expand use of the drug to treat more conditions.Argenx on ","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["ARGX","LU0823416689.USD","IE00B4R5TH58.HKD","BK4588","IE00B2B36J28.USD","LU1983260115.SGD","IE0034235188.USD","IE00BJJMRZ35.SGD","LU0109394709.USD","BK4505","IE0009355771.USD","IBB","BK4585","FMED","BK4139","LU0889565916.HKD","IE0002141913.USD","LU2324357040.USD","IE00BFTCPJ56.SGD","LU0320765992.SGD","TBXU","IE00BJT1NW94.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660431812","title":"Vortex Energy Appoints Market Maker to Boost Liquidity on CSE","url":"https://stock-news.laohu8.com/highlight/detail?id=2660431812","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660431812?lang=en_us&edition=fundamental","pubTime":"2026-08-18 01:07","pubTimestamp":1786986428,"startTime":"0","endTime":"0","summary":"An announcement from Vortex Energy Corp. ( ($TSE:VRTX) ) is now available. Vortex Energy Corp., a North American mineral exploration company, is ad...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/vortex-energy-appoints-market-maker-to-boost-liquidity-on-cse?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/vortex-energy-appoints-market-maker-to-boost-liquidity-on-cse?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4588","LU0417517546.SGD","LU0079474960.USD","BK4139","LU0234570918.USD","BK4567","LU2237438978.USD","LU1093756168.USD","IE0002141913.USD","LU0256863811.USD","LU1430594728.SGD","LU0432979614.USD","IE00B19Z9Z06.USD","LU2236285917.USD","IE00B894F039.SGD","LU0823416689.USD","LU1778281490.HKD","LU2324357040.USD","SG9999001176.USD","GNMX","IE0009355771.USD","LU2089984988.USD","LU0109394709.USD","LU2362541273.HKD","IE00B19Z3581.USD","IE00BJT1NW94.SGD","LU0058720904.USD","LU0889565916.HKD","BK4533","IE0002270589.USD","IE00B19Z9P08.USD","LU2468319806.SGD","LU0320765992.SGD","LU1069344957.HKD","LU0289739699.SGD","BK4585","IDNA","VRTX","LU2362540622.SGD","SG9999013999.USD","BIB","IBBQ","LU2417539215.USD","IE00BFTCPJ56.SGD","LU0061475181.USD","TBXU","BBH","PBE","IBB","LU2362541513.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660650439","title":"argenx SE Stock (ARGX) Moved Up by 16.67% on Aug 17: Drivers Behind the Movement","url":"https://stock-news.laohu8.com/highlight/detail?id=2660650439","media":"TradingKey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660650439?lang=en_us&edition=fundamental","pubTime":"2026-08-18 00:15","pubTimestamp":1786983324,"startTime":"0","endTime":"0","summary":"• Argenx announced positive Phase 3 ALKIVIA study results for VYVGART Hytrulo in myositis.\n• The company reported $4.15 billion in annual revenue and $1.29 billion in net profit.\n• Analysts issued Buy ratings with an average price target of $1083.77.","market":"sh","thumbnail":"https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg","type":0,"news_type":0,"thumbnails":["https://resource.tradingkey.com/cms_uploads/img/20230814/292a73ea96beb98e5f665e124a82e00c.jpg"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tradingkey.com/news/market-movers/262112694-market-movers-argx-20260817","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","FMED","IE00B2B36J28.USD","IE0034235188.USD","IE00BJT1NW94.SGD","BK4139","IE0009355771.USD","IE00BJJMRZ35.SGD","LU1983260115.SGD","IE0002141913.USD","BK4588","IE00BFTCPJ56.SGD","TBXU","LU0109394709.USD","IE00B4R5TH58.HKD","BK4585","LU0823416689.USD","LU0889565916.HKD","IBB","LU2324357040.USD","LU0320765992.SGD","ARGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660439344","title":"Argenx Price Target Raised to $1215.00/Share from $1075.00 by Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2660439344","media":"Dow Jones","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660439344?lang=en_us&edition=fundamental","pubTime":"2026-08-18 00:07","pubTimestamp":1786982820,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/ARGX/analyst-ratings","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4505","FMED","IE00B2B36J28.USD","IE0034235188.USD","IE00BJT1NW94.SGD","BK4139","IE0009355771.USD","IE00BJJMRZ35.SGD","LU1983260115.SGD","IE0002141913.USD","BK4588","IE00BFTCPJ56.SGD","TBXU","LU0109394709.USD","IE00B4R5TH58.HKD","BK4585","LU0823416689.USD","LU0889565916.HKD","IBB","LU2324357040.USD","LU0320765992.SGD","ARGX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660323436","title":"European Equities Traded in the US as American Depositary Receipts Open Week Higher in Monday Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=2660323436","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660323436?lang=en_us&edition=fundamental","pubTime":"2026-08-17 23:12","pubTimestamp":1786979555,"startTime":"0","endTime":"0","summary":"European equities traded in the US as American depositary receipts started the week tracking modestly higher late Monday morning, rising 0.31% to 1,970.56 on the S&P Europe Select ADR Index.From continental Europe, the gainers were led by biopharmaceutical companies argenx  and DBV Technologies , which climbed 16% and 5.1% respectively. They were followed by telecommunications company Nokia  and biopharmaceutical company Cellectis , which advanced 2.5% and 2% respectively.The decliners from continental Europe were led by medical device maker EDAP TMS  and internet browser company Opera , which dropped 4.6% and 2.7% respectively. They were followed by brewing company Anheuser-Busch InBev  and consumer goods company Unilever , which lost 2.4% and 1.6% respectively.The gainers from the UK were led by biotech firm Autolus Therapeutics  and biopharmaceutical company Akari Therapeutics , which rose 6.3% and 2.8% respectively. They were followed by biopharmaceutical companies GSK  and Bicycle","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["ARGX","GSKH","AKTX","AFG","DEO","BK4532","DGE.UK","IEUR","MREO","NOK","OPRA","FMED","IE00B4R5TH58.HKD","UL","IE0002141913.USD","BK4009","LNOK","TBXU","BK4117","WPP","BUD","GSK.UK","IE00BFTCPJ56.SGD","BK4505","FOCL","IE00BMPRXN33.USD","IE00BJJMRZ35.SGD","ULVR.UK","BK4139","LU0823416689.USD","GSK","BK4592","LU0006061336.USD","BCYC","LFGY","BK4169","CLLS","DBVT","BUD.AU","BK4588","EPV","IBB","LU0889565916.HKD","UN","BK4007","AUTL","LU1983260115.SGD","BK4107","NCNA","WPP.AU"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660543552","title":"Wedbush Adjusts Argenx PT to $1,150 From $1,050, Maintains Outperform Rating","url":"https://stock-news.laohu8.com/highlight/detail?id=2660543552","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660543552?lang=en_us&edition=fundamental","pubTime":"2026-08-17 22:35","pubTimestamp":1786977309,"startTime":"0","endTime":"0","summary":"Argenx (ARGX) has an average rating of buy and mean price target of $1,094.70, according to analysts polled by FactSet.(MT Newswires covers equity, commodity and economic research from major banks and","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1983260115.SGD","IE0009355771.USD","IE00BJT1NW94.SGD","TBXU","LU0823416689.USD","LU0109394709.USD","LU0889565916.HKD","IE0002141913.USD","IE0034235188.USD","FMED","BK4585","IE00B2B36J28.USD","BK4139","ARGX","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","LU0320765992.SGD","LU2324357040.USD","IBB","BK4588","BK4505","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660433030","title":"Argenx SE (ARGX) Stock Soars 15% on Positive Phase 3 Study Results","url":"https://stock-news.laohu8.com/highlight/detail?id=2660433030","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660433030?lang=en_us&edition=fundamental","pubTime":"2026-08-17 22:11","pubTimestamp":1786975871,"startTime":"0","endTime":"0","summary":"Argenx SE stock was up 15.25% on Monday after the company posted results from its ALKIVIA Phase 3 study.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/argenx-se-argx-stock-soars-15-on-positive-phase-3-study-results?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/argenx-se-argx-stock-soars-15-on-positive-phase-3-study-results?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU0889565916.HKD","IE00B4R5TH58.HKD","IE0002141913.USD","TBXU","IE0009355771.USD","BK4588","IE00BJJMRZ35.SGD","LU1983260115.SGD","LU0109394709.USD","BK4585","BK4139","LU2324357040.USD","IBB","IE00BFTCPJ56.SGD","ARGX","IE00B2B36J28.USD","FMED","BK4505","IE0034235188.USD","IE00BJT1NW94.SGD","LU0320765992.SGD","LU0823416689.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660433417","title":"Argenx SE up over 15%, on Pace for Largest Percent Increase Since July 2023","url":"https://stock-news.laohu8.com/highlight/detail?id=2660433417","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660433417?lang=en_us&edition=fundamental","pubTime":"2026-08-17 22:08","pubTimestamp":1786975680,"startTime":"0","endTime":"0","summary":"argenx SE Sponsored ADR  is currently at $979.54, up $128.25 or 15.07%--Would be new all-time closing high --Would be the first record close since July 2, 2026, when it closed at $939.68--On pace for largest percent increase since July 17, 2023, when it rose 27.79%--Snaps a two day losing streak--Up 14.72% month-to-date--Up 16.48% year-to-date--Up 48.12% from 52 weeks ago , when it closed at $661.32--Would be a new 52-week closing high--Up 49.12% from its 52-week closing low of $656.89 on Aug. 19, 2025--Traded as high as $982.95; new all-time intraday high --Up 15.47% at today's intraday high; largest intraday percent increase since July 17, 2023, when it rose as much as 31.54%All data as of 10:02:39 AM ETSource: Dow Jones Market Data, FactSet","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1983260115.SGD","IE0009355771.USD","IE00BJT1NW94.SGD","TBXU","LU0823416689.USD","LU0109394709.USD","LU0889565916.HKD","IE0002141913.USD","IE0034235188.USD","FMED","BK4585","IE00B2B36J28.USD","BK4139","ARGX","IE00BJJMRZ35.SGD","IE00B4R5TH58.HKD","LU0320765992.SGD","LU2324357040.USD","IBB","BK4588","BK4505","IE00BFTCPJ56.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660743398","title":"Argenx rises 14.9%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660743398","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660743398?lang=en_us&edition=fundamental","pubTime":"2026-08-17 22:00","pubTimestamp":1786975211,"startTime":"0","endTime":"0","summary":"Argenx (ARGX) is up 14.9%, or $126.60 to $977.89. Published first on TheFly – the ultimate source for real-time, market-moving breaking financial n...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/argenx-rises-14-9-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/argenx-rises-14-9-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["ARGX","IE00B2B36J28.USD","IE0002141913.USD","LU2324357040.USD","TBXU","BK4588","IE00BJT1NW94.SGD","IE00BFTCPJ56.SGD","IE00B4R5TH58.HKD","IBB","LU1983260115.SGD","LU0823416689.USD","FMED","IE00BJJMRZ35.SGD","IE0034235188.USD","IE0009355771.USD","LU0889565916.HKD","BK4139","BK4505","LU0109394709.USD","LU0320765992.SGD","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660480066","title":"Sector Update: Healthcare","url":"https://stock-news.laohu8.com/highlight/detail?id=2660480066","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660480066?lang=en_us&edition=fundamental","pubTime":"2026-08-17 21:04","pubTimestamp":1786971840,"startTime":"0","endTime":"0","summary":"Healthcare stocks were mixed premarket Monday, with the State Street Health Care Select Sector SPDR ETF  0.5% lower and the iShares Biotechnology ETF  up 0.2%.Argenx  shares were nearly 12% higher after the company said a phase 3 study evaluating its experimental drug, Vyvgart Hytrulo, in adults with autoimmune myositis met its main goal.","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["FMED","BK4135","BK4139","BK4588","LU0061475181.USD","LU2324357040.USD","IE00B4R5TH58.HKD","LU1983260115.SGD","STT","BK4550","BK4505","IE00BJJMRZ35.SGD","XLV","IE00B64PRP62.GBP","LU0320765992.SGD","HCSG","LU1894683348.USD","LU0128526141.USD","IE00B3QW5Z07.USD","IE00B2B36J28.USD","IE00BGHQF748.EUR","TBXU","LABU","IE00BJT1NW94.SGD","XBI","IE0002141913.USD","BK4585","IBB","BK4137","ARGX","LU0889565916.HKD","LU1894683264.USD","BK4581","LU1883839398.USD","LU0823416689.USD","IE0009355771.USD","IE00BFTCPJ56.SGD","LU0029874061.USD","LU0109394709.USD","FDN","IE0034235188.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660480606","title":"Regeneron Pharma Price Target Raised to $824.00/Share from $641.00 by Leerink Partners","url":"https://stock-news.laohu8.com/highlight/detail?id=2660480606","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660480606?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:45","pubTimestamp":1786970700,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/REGN/analyst-ratings","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0053666078.USD","LU0823434740.USD","LU2468319806.SGD","LU2089984988.USD","LU0320765992.SGD","LU0823434583.USD","LU2106854487.HKD","IBB","BK4588","LU1974910355.USD","TBXU","LU2023250504.SGD","LU0882574055.USD","LU2362540622.SGD","LU0114720955.EUR","LU0058720904.USD","IBBQ","LU0109394709.USD","LU2362541513.USD","LU1917777945.USD","LU2362541273.HKD","LU0823416689.USD","LU0889565916.HKD","LU0289739699.SGD","BK4139","LU2237438978.USD","REGN","BBH","BK4585"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660487894","title":"EyePoint Tumbles After Experimental Eye Drug Misses Main Goal in Late-Stage Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2660487894","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660487894?lang=en_us&edition=fundamental","pubTime":"2026-08-17 20:06","pubTimestamp":1786968371,"startTime":"0","endTime":"0","summary":"BUZZ-EyePoint tumbles after experimental eye drug misses main goal in late-stage study** Shares of drug developer EyePointEYPT.Ofell 62.7% to $5.50 premarket** Co says experimental eye drug Duravyumissed the main goalof a late-stage trial against Regeneron's blockbuster eye drug Eylea in patients with wet age-related macular degeneration, a leading cause of vision loss** EYPT says an analysis excluding nine patients whose vision loss was unrelated to wet AMD showed Duravyu performed similarly to Eylea** Co says Duravyu reduced treatment burden by 42% versus Eylea, or about two fewer injections through Week 56** EYPT says 54% of patients were supplement-free through Week 56 and 79% received zero or one supplemental injection** Co expects data from a second late-stage wet AMD study in Q4 2026 and plans a potential FDA filing in H1 2027** As of last close, stock down ~19% YTD","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260817:nL4N44E0Q6:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1974910355.USD","REGN","LU0053666078.USD","TBXU","BBH","LU0109394709.USD","LU0889565916.HKD","LU2362541273.HKD","IBB","LU0114720955.EUR","BK4007","LU2237438978.USD","LU2106854487.HKD","LU0823434583.USD","IBBQ","BK4588","LU0320765992.SGD","LU2023250504.SGD","LU2468319806.SGD","LU0823416689.USD","LU0823434740.USD","LU0289739699.SGD","BK4585","EYPT","LU2089984988.USD","LU1917777945.USD","LU0058720904.USD","BK4139","LU2362540622.SGD","LU2362541513.USD","LU0882574055.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660484769","title":"Argenx price target raised to $1,215 from $1,075 at Piper Sandler","url":"https://stock-news.laohu8.com/highlight/detail?id=2660484769","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660484769?lang=en_us&edition=fundamental","pubTime":"2026-08-17 19:13","pubTimestamp":1786965211,"startTime":"0","endTime":"0","summary":"Piper Sandler raised the firm’s price target on Argenx (ARGX) to $1,215 from $1,075 and keeps an Overweight rating on the shares. With Q2 2026 repo...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/argenx-price-target-raised-to-1215-from-1075-at-piper-sandler-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/argenx-price-target-raised-to-1215-from-1075-at-piper-sandler-thefly-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4505","TBXU","IE00BFTCPJ56.SGD","IE00BJJMRZ35.SGD","LU0889565916.HKD","ARGX","IE0002141913.USD","IE00B4R5TH58.HKD","FMED","IE0034235188.USD","IBB","LU0109394709.USD","BK4585","IE00B2B36J28.USD","LU0320765992.SGD","BK4139","LU2324357040.USD","IE00BJT1NW94.SGD","LU1983260115.SGD","LU0823416689.USD","BK4588","IE0009355771.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660483685","title":"argenx Says Autoimmune Myositis Drug Meets Main Goal in Phase 3 Study","url":"https://stock-news.laohu8.com/highlight/detail?id=2660483685","media":"MT Newswires Live","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660483685?lang=en_us&edition=fundamental","pubTime":"2026-08-17 16:25","pubTimestamp":1786955131,"startTime":"0","endTime":"0","summary":"argenx  said a phase 3 study evaluating its experimental drug, Vyvgart Hytrulo, in adults with autoimmune myositis met main goal.The company said the patients treated with the drug showed a statistically significant improvement in mean total improvement score at week 52 compared with placebo.Treatment benefits emerged as early as week 4 and were sustained through the 52-week treatment period, including during steroid tapering, the company said.argenx said the primary endpoint was also met in patients with immune-mediated necrotizing myopathy, while dermatomyositis patients showed a similar improvement, although it did not reach statistical significance.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["IE00B4R5TH58.HKD","ARGX","BK4585","IE0009355771.USD","IE00BFTCPJ56.SGD","BK4139","LU1983260115.SGD","IE0034235188.USD","IE0002141913.USD","BK4588","LU0320765992.SGD","LU0823416689.USD","LU0889565916.HKD","TBXU","LU2324357040.USD","LU0109394709.USD","IE00B2B36J28.USD","IBB","FMED","BK4505","IE00BJT1NW94.SGD","IE00BJJMRZ35.SGD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660948803","title":"Argenx Shares Rise After Positive Results from Phase 3 Study of Efgartigimod","url":"https://stock-news.laohu8.com/highlight/detail?id=2660948803","media":"Dow Jones","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660948803?lang=en_us&edition=fundamental","pubTime":"2026-08-17 16:08","pubTimestamp":1786954080,"startTime":"0","endTime":"0","summary":"Shares in Argenx rose after the European pharmaceutical company reported positive results from the phase 3 trial of Efgartigimod for the treatment of autoimmune myositis.In early morning trading, shar","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Argenx Shares Rise After Positive Results from Phase 3 Study of Efgartigimod","news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BJT1NW94.SGD","LU0109394709.USD","IE00BJJMRZ35.SGD","IE0009355771.USD","IE00B4R5TH58.HKD","BK4139","IE00BFTCPJ56.SGD","IE0034235188.USD","IE0002141913.USD","LU0823416689.USD","FMED","TBXU","LU1983260115.SGD","BK4505","LU0889565916.HKD","LU0320765992.SGD","IBB","ARGX","IE00B2B36J28.USD","BK4585","BK4588","LU2324357040.USD"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":4,"totalSize":200,"code":"91000000","status":"200"}]}}